MDA selects NC and Raytheon to further develop Glide Phase Interceptor prototype
The Department of Defense has awarded two firm fixed price Other Transaction (OT) Agreement modifications to exercise options; one to Northrop Grumman and one to Raytheon through the Missile Defense Agency's (MDA) authority under 10 U.S.C. 4022. Each modification has an approximate value of $41.5M and an anticipated Period of Performance through February 2023. These modifications will allo